Logo image of HERMA.OL

HERMANA HOLDING ASA (HERMA.OL) Stock Fundamental Analysis

OSL:HERMA - NO0013401380 - Common Stock

13.3 NOK
-0.2 (-1.48%)
Last: 9/11/2025, 7:00:00 PM
Fundamental Rating

3

Taking everything into account, HERMA scores 3 out of 10 in our fundamental rating. HERMA was compared to 37 industry peers in the Energy Equipment & Services industry. HERMA has a great financial health rating, but its profitability evaluates not so good. HERMA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

HERMA had positive earnings in the past year.
HERMA had a negative operating cash flow in the past year.
HERMA.OL Yearly Net Income VS EBIT VS OCF VS FCFHERMA.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 20M 40M 60M 80M

1.2 Ratios

HERMA's Return On Assets of 2.78% is on the low side compared to the rest of the industry. HERMA is outperformed by 62.16% of its industry peers.
The Return On Equity of HERMA (2.80%) is worse than 72.97% of its industry peers.
Industry RankSector Rank
ROA 2.78%
ROE 2.8%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HERMA.OL Yearly ROA, ROE, ROICHERMA.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 200 400 600

1.3 Margins

With an excellent Profit Margin value of 47.89%, HERMA belongs to the best of the industry, outperforming 97.30% of the companies in the same industry.
In the last couple of years the Profit Margin of HERMA has declined.
The Operating Margin and Gross Margin are not available for HERMA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 47.89%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-22.65%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HERMA.OL Yearly Profit, Operating, Gross MarginsHERMA.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -100 -200

More info and screens

7

2. Health

2.1 Basic Checks

HERMA has about the same amout of shares outstanding than it did 1 year ago.
There is no outstanding debt for HERMA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
HERMA.OL Yearly Shares OutstandingHERMA.OL Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2M 4M 6M 8M 10M
HERMA.OL Yearly Total Debt VS Total AssetsHERMA.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

There is no outstanding debt for HERMA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
HERMA.OL Yearly LT Debt VS Equity VS FCFHERMA.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

HERMA has a Current Ratio of 127.33. This indicates that HERMA is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of HERMA (127.33) is better than 100.00% of its industry peers.
HERMA has a Quick Ratio of 127.33. This indicates that HERMA is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of HERMA (127.33) is better than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 127.33
Quick Ratio 127.33
HERMA.OL Yearly Current Assets VS Current LiabilitesHERMA.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for HERMA have decreased strongly by -65.30% in the last year.
The earnings per share for HERMA have been decreasing by -49.24% on average. This is quite bad
Looking at the last year, HERMA shows a very negative growth in Revenue. The Revenue has decreased by -62.14% in the last year.
HERMA shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -34.38% yearly.
EPS 1Y (TTM)-65.3%
EPS 3Y-49.24%
EPS 5YN/A
EPS Q2Q%528.16%
Revenue 1Y (TTM)-62.14%
Revenue growth 3Y-34.38%
Revenue growth 5YN/A
Sales Q2Q%-100%

3.2 Future

The Earnings Per Share is expected to decrease by -105.41% on average over the next years. This is quite bad
The Revenue is expected to decrease by -25.99% on average over the next years. This is quite bad
EPS Next Y-1550%
EPS Next 2Y-194.39%
EPS Next 3Y-105.41%
EPS Next 5YN/A
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
HERMA.OL Yearly Revenue VS EstimatesHERMA.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 20M 40M 60M 80M
HERMA.OL Yearly EPS VS EstimatesHERMA.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 53.20, which means the current valuation is very expensive for HERMA.
HERMA's Price/Earnings ratio is a bit more expensive when compared to the industry. HERMA is more expensive than 72.97% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.44. HERMA is valued rather expensively when compared to this.
HERMA is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 53.2
Fwd PE N/A
HERMA.OL Price Earnings VS Forward Price EarningsHERMA.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HERMA.OL Per share dataHERMA.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

A cheap valuation may be justified as HERMA's earnings are expected to decrease with -105.41% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-194.39%
EPS Next 3Y-105.41%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for HERMA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HERMANA HOLDING ASA

OSL:HERMA (9/11/2025, 7:00:00 PM)

13.3

-0.2 (-1.48%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.22%
Inst Owner ChangeN/A
Ins Owners0.44%
Ins Owner ChangeN/A
Market Cap178.49M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-65%
EPS NY rev (3m)-65%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 53.2
Fwd PE N/A
P/S 25.14
P/FCF N/A
P/OCF N/A
P/B 1.47
P/tB 1.47
EV/EBITDA N/A
EPS(TTM)0.25
EY1.88%
EPS(NY)-1.02
Fwd EYN/A
FCF(TTM)-0.63
FCFYN/A
OCF(TTM)-0.63
OCFYN/A
SpS0.53
BVpS9.05
TBVpS9.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.78%
ROE 2.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 47.89%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-22.65%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 127.33
Quick Ratio 127.33
Altman-Z N/A
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-65.3%
EPS 3Y-49.24%
EPS 5YN/A
EPS Q2Q%528.16%
EPS Next Y-1550%
EPS Next 2Y-194.39%
EPS Next 3Y-105.41%
EPS Next 5YN/A
Revenue 1Y (TTM)-62.14%
Revenue growth 3Y-34.38%
Revenue growth 5YN/A
Sales Q2Q%-100%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5YN/A
EBIT growth 1Y-396.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year0%
EBIT Next 3Y0%
EBIT Next 5YN/A
FCF growth 1Y-110.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-110.47%
OCF growth 3YN/A
OCF growth 5YN/A